Effects of Hydrogen Water Gargling on Oral Mucositis and Pain in Head and Neck Cancer Patients: A Randomized Controlled Pilot Study.
Hui-Ting Tsai, Chih-Jen Huang, Hui-Ching Wang, Sheng-Dean Luo, Kun-Ming Rau, Pi-Ling Chou · Integrative cancer therapies · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In participants with radiotherapy or concurrent chemo-radiotherapy, qoL improved in the HW group (p = 0.03), while OFC scores showed no significant difference between groups (p = 0.74). These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in participants with radiotherapy or concurrent chemo-radiotherapy. QoL improved in the HW group (p = 0.03), while OFC scores showed no significant difference between groups (p = 0.74).
What the Researchers Studied
The researchers studied participants with radiotherapy or concurrent chemo-radiotherapy. The study used a randomized human clinical trial.
What Effects Did Molecular Hydrogen Have?
QoL improved in the HW group (p = 0.03), while OFC scores showed no significant difference between groups (p = 0.74).
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a randomized human clinical trial. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was participants with radiotherapy or concurrent chemo-radiotherapy. The study used a randomized human clinical trial.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.